Patent · US Active

Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile

US7956063B2 · kind B2 · utility

6Cited by

10References

7Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Jérôme Emile Georges Guillemont · Andé, FR
Paul Theodoor Agnes Stevens · Turnhout, BE
Alex Herman Copmans · Beerse, BE
Jozef Peeters · Ieper, BE
Alfred Elisabeth Stappers · Oud-Turnhout, BE
Roger Petrus Gerebern Vandecruys · Westerlo, BE
Paul Stoffels · Hoogstraten, BE

Key dates

Filing date	Jul 7, 2008
Grant date	Jun 7, 2011
Priority date	—
Expiry date	Aug 7, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/48
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a pharmaceutical composition comprising as active ingredient the hydrochloric acid salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethyl-phenyl]amino]-2-pyrimidinyl]amino]benzonitrile and to processes for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.